This $1,971,886 project grant from the Department of the Army Medical Command, under the Military Medical Research and Development program (CFDA 12.420), supports research exploring the impact of microprocessor-controlled knees on prosthesis awareness and overall health. Virginia Commonwealth University is the primary awardee and will work with sub-awardees Hanger, Inc. and the University of Washington on this research from July 2021 through June 2025. The grant aims to transform military and...
This $1,499,872 Project Grant was awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to Results Group, LLC, a small disadvantaged business specializing in advanced assistive technologies and rehabilitation devices. The grant supports the development of an exoskeleton-integrated boot system to facilitate longer-term rehabilitation and return to duty for military personnel recovering from lateral ankle sprains. The innovative solution...
The Defense Health Agency awarded a $1,493,220 Project Grant to The Cleveland VA Medical Research & Education Foundation under the Military Medical Research and Development program (CFDA 12.420). The grant supports the development of a "Neurally Integrated Lower Limb Prosthesis for Home and Community Use" to aid mobility and sensory restoration for wounded veterans. The 4-year project, running from September 2023 to August 2027, aligns with the program's priorities of advancing...
The Rehabilitation Institute of Chicago, doing business as Shirley Ryan AbilityLab, will conduct the "POWER FORWARD STUDY: A CROSS-SECTOR, MULTISITE CLINICAL TRIAL OF A POWERED KNEE-ANKLE-FOOT ORTHOSIS" project under a $1.679 million project grant from the Department of the Army Medical Command. The grant was awarded on August 1, 2022 and will support project activities through July 31, 2026. The project aims to transform health care for service members and the public through...
This Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program provides $505,228.00 to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. to investigate joint-level biomechanics and pathomechanics in simulated ambulation after lower limb loss. The research aims to identify strategies for preserving knee joint health in individuals who have experienced lower limb amputation. The award period runs from...
The University of Texas at Austin was awarded a $1,499,767 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) to investigate the impact of personalized robotic leg prostheses for individuals with transfemoral amputations of varying mobility levels. The research will be conducted from September 2022 through September 2026. A subaward of $150,000 was provided to the Georgia Tech Research Corporation to support...
The University of Utah was awarded a $1,498,742 project grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund the development of a motorized hip orthosis for individuals with transfemoral amputations over a four-year period ending September 2026. The orthosis aims to improve mobility and independence for those with upper leg amputations through powered assistance technology. As part of its broader...
The University of Utah received a $1,499,903 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to develop a "HIGH-PERFORMANCE POWERED ANKLE/FOOT PROSTHESIS FOR BELOW-KNEE AMPUTEES". The award has a performance period from August 1, 2024 to July 31, 2028. As part of this grant, the University of Utah is collaborating with a subrecipient, Otto Bock Healthcare LP, a prosthetics manufacturer, to design and produce...
This federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) provides $2,467,635.00 to the University of South Florida to conduct "The IM ABLE 2 STUDY: Long Term Outcomes to Advance Care for Warriors and Veterans Using Advanced Ankle Foot Orthoses" over a performance period from June 15, 2025 to June 14, 2029. The research aims to advance biomedical solutions and transform healthcare for...
The University of South Australia was awarded a $264,887.70 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on using mediated reality to reduce knee osteoarthritis pain and improve exercise engagement. The award period runs from July 1, 2024 to June 30, 2026. This research project aims to develop innovative therapeutic approaches leveraging mediated reality technology to alleviate symptoms of knee...